#United States #San Francisco #Carta Healthcare #Haas Awards #Hybrid Intelligence

Carta Healthcare's Impressive Growth in 2025

In the dynamic landscape of healthcare, Carta Healthcare, a prominent leader in clinical data management, has made headlines by achieving unparalleled growth in 2025. This growth surge is a testament to the company’s innovative solutions and the rising demand for their Hybrid Intelligence approach.

Unprecedented Customer Retention and Expansion

One of the highlights of Carta's remarkable progress is its 100% customer retention rate. Additionally, the company proudly announced the signing of 25 new contracts, welcoming 10 hospitals that transitioned to Carta from competing clinical data abstraction providers. This robust expansion coincided with the impressive doubling of its revenue and an increase in staff, with 144 new hires joining the team to meet the growing demand for its services.

The Rise of Hybrid Intelligence in Clinical Data Management

Hybrid Intelligence, a cutting-edge model that integrates advanced artificial intelligence with expert clinical oversight, is driving this market shift. This innovative model has proven to enhance accuracy and efficiency in clinical data management, significantly reducing costs and manual effort. Health systems leveraging Carta's solutions report a staggering 66% reduction in abstraction time and more than 50% decrease in costs, achieving data reliability rates between 98-99%. According to Carta’s CEO Brent Dover, this model is not just about speed but emphasizes the critical need for accuracy and clinical validation in the healthcare sector.

Celebrating Industry Recognition

The year 2025 also brought numerous accolades to Carta Healthcare, solidifying its standing as a pioneer in health technology innovation. The company was honored with several prestigious awards, signifying its contribution to healthcare improvement and technological advancements.

• - 2025 Merit Awards for Healthcare - Best Use of AI in Healthcare (Gold)
• - 2025 CB Insights Digital Health 50 - Clinical Workflow Automation Category
• - 2025 A.I. Awards - Finalist for Best Use of AI in Healthcare
• - 2025 Silver Stevie® Award - Technical Innovation of the Year
• - 2025 BIG Innovation Award - Healthcare
• - 2025 Pinnacle Awards - Diamond Award for AI Automation Leadership

These recognitions affirm the effectiveness and transformative impact of Carta’s technologies within the industry.

A Funding Boost for Further Growth

In addition to its operational success, Carta Healthcare gained significant financial backing through a $18.25 million Series B1 funding round in May 2025. This funding, led by UPMC Enterprises and supported by other notable investors, is earmarked for expanding Carta’s footprint in the healthcare sector and further developing its innovative solutions. The alignment of interests between Carta and its investors underscores the growing confidence in the benefits that Hybrid Intelligence brings to hospitals nationwide.

Enhancing Outsourced Abstraction Models

As many organizations turn towards outsourcing clinical abstraction services, Carta continues to impress with its ability to offer value through its Hybrid Intelligence platform. The company firmly believes that outsourcing does not have to mean relying on outdated processes. Through its tech-enabled services, Carta is demonstrating that all clients, even those who don’t directly use the technology, can benefit from improved speed, accuracy, and reliability in data management.

Conclusion

At its core, Carta Healthcare is committed to creating a future where high-quality data leads to better healthcare outcomes. Its innovative approach is redefining traditional clinical data abstraction, making it more efficient and less burdensome. With their 100% customer retention rate and numerous industry accolades, Carta is indeed paving the way for a new era in healthcare data management. For more about their work and future advancements, visit Carta Healthcare’s website.